Pregnancy, Childbirth & Puerperium

Labor management: stages and dystocia

Clinical Overview and When to Suspect Labor Dystocia

— Stage 1: onset of regular contractions → full cervical dilation (10 cm)

— Latent phase: 0 → 6 cm (highly variable duration, can exceed 20 h in nulliparas)

— Active phase: 6 cm → 10 cm (expect ≥1 cm/h, but slower is now accepted)

— Stage 2: full dilation → delivery of fetus

— Stage 3: delivery of fetus → delivery of placenta (normal ≤30 min)

— Stage 4: first 1–2 h postpartum (hemodynamic stabilization)

— Power: inadequate uterine contractions (most common, correctable)

— Passenger: fetal size, malpresentation, malposition (OP, asynclitism), anomalies

— Passage: bony pelvis or soft tissue (fibroids, full bladder, scarring)

— Protracted active phase: <1 cm/h dilation after 6 cm

— Arrest of dilation: no cervical change ≥4 h with adequate contractions OR ≥6 h with inadequate contractions, at ≥6 cm

— Arrest of descent (stage 2): nullipara >3 h (>4 h with epidural); multipara >2 h (>3 h with epidural)

Labor dystocia = abnormally slow or arrested progress of labor, the leading indication for primary cesarean delivery in the US (responsible for ~30% of primary C-sections)

Normal labor is divided into stages:

The 3 P's framework for dystocia etiology:

When to suspect dystocia:

Board pearl: ACOG/SMFM redefined the active phase to begin at 6 cm (not 4 cm as in Friedman's older curve). Diagnosing "arrest" before 6 cm leads to unnecessary cesareans — a frequent Step 3 distractor.

Key distinction: Protraction = slow but progressing; arrest = no progress despite adequate forces. Management differs: protraction tolerates expectant management + oxytocin; arrest at adequate contractions typically mandates cesarean.

Presentation Patterns and Key History

— GTPAL (gravidity, term, preterm, abortions, living children) — prior precipitous labor or shoulder dystocia predicts recurrence

— EDD and dating method (LMP vs first-trimester US; first-trimester US is most accurate)

— Prenatal course: GDM, hypertensive disorders, GBS status, fetal growth (LGA/macrosomia raises dystocia and shoulder dystocia risk)

— Prior deliveries: route, birth weights, lacerations, postpartum hemorrhage, prior cesarean (TOLAC eligibility)

— Onset, frequency, duration, intensity

— True labor: regular, increasing intensity, cervical change

— False labor (Braxton-Hicks): irregular, no cervical change → discharge with reassurance

— Nulliparity, advanced maternal age, obesity (BMI >30), short stature

— Macrosomia (>4000 g; >4500 g in diabetics raises shoulder dystocia risk markedly)

— Post-term pregnancy, polyhydramnios, prior dystocia

— Epidural analgesia (mildly prolongs stage 2; not an indication to limit use)

— Chorioamnionitis (impairs contractility)

Laboring patient presents to L&D triage; obtain a focused history:

Contraction history:

Membrane status: SROM time, fluid color (meconium → fetal surveillance), Nitrazine/ferning if uncertain

Bleeding: bloody show is normal; heavy bleeding → rule out abruption or previa before exam

Risk factors for dystocia (high-yield):

Step 3 management: A G2P1 at 41w0d with prior 4200 g delivery and current EFW 4300 g presents in early labor — counsel on shoulder dystocia risk, prepare for McRoberts maneuver, and have anesthesia/NICU on standby. Offer scheduled cesarean if EFW ≥5000 g (≥4500 g in diabetics) per ACOG.

Board pearl: Do not perform digital cervical exam in suspected previa or active vaginal bleeding without prior ultrasound — risk of catastrophic hemorrhage.

Physical Exam Findings and Maternal–Fetal Assessment

— Maternal fever ≥39.0°C (or 38.0–38.9°C with another criterion) → intrapartum chorioamnionitis (Triple I) workup

— Hypertension → preeclampsia evaluation (proteinuria, labs, symptoms)

— Leopold maneuvers: fetal lie, presentation, position, engagement, EFW

— Fundal height, contraction palpation (intensity, tone between contractions)

— Dilation (cm), effacement (%), station (–5 to +5 relative to ischial spines; 0 = engaged)

— Position (OA, OP, OT) — malposition (OP) is a common reversible cause of arrest

— Membrane status, presenting part, caput/molding

— Pelvimetry: prominent ischial spines, narrow subpubic arch, flat sacrum suggest contracted pelvis

— Category I (normal): baseline 110–160, moderate variability, accelerations, no late/variable decels

— Category II (indeterminate): everything else — requires evaluation and intervention

— Category III (abnormal): absent variability + recurrent late/variable decels OR bradycardia OR sinusoidal pattern → prompt delivery

— External tocodynamometer shows frequency only

— Intrauterine pressure catheter (IUPC) quantifies Montevideo units (MVUs) = sum of contraction amplitudes above baseline over 10 min

— Adequate labor: ≥200 MVU

Maternal vitals on admission: BP, HR, RR, T, SpO₂; recheck per protocol (q1–4h depending on stage and risk)

Abdominal exam:

Sterile vaginal exam (SVE):

Fetal heart rate (FHR) monitoring:

Contraction adequacy:

CCS pearl: When evaluating possible arrest of active phase, order IUPC placement to document MVU before diagnosing arrest — arrest requires ≥4 h of adequate (≥200 MVU) contractions without cervical change, or ≥6 h with inadequate contractions despite oxytocin.

Key distinction: Engagement (station 0) ≠ full dilation. A high station at full dilation predicts difficult second stage.

Diagnostic Workup — Admission Labs, Monitoring, and Initial Studies

— CBC (baseline Hgb for PPH risk; platelets for neuraxial anesthesia — generally need ≥70k for epidural)

— Type and screen (type and crossmatch if hemorrhage risk: previa, accreta, prior PPH, anticoagulation)

— HIV (if status unknown — opt-out testing in labor per CDC)

— GBS status review (intrapartum penicillin if positive, unknown with risk factors, or prior GBS-affected infant)

— Urinalysis if preeclampsia suspected; CMP, LDH, uric acid for preeclampsia labs

— Low-risk: intermittent auscultation acceptable (q15 min stage 1 active, q5 min stage 2) OR continuous EFM

— High-risk (preeclampsia, GDM on insulin, IUGR, prior cesarean, oxytocin, meconium): continuous EFM mandatory

— Confirm presentation if Leopold uncertain (breech detection critical before pushing)

— Assess fetal position (OP vs OA) when SVE is ambiguous and stage 2 is prolonged

— AFI for oligo/polyhydramnios

— Placental location if any bleeding

— Sterile speculum: pooling, Nitrazine (alkaline amniotic fluid turns blue), ferning on microscopy

— Commercial tests (AmniSure/PAMG-1) if equivocal

— Avoid digital exam in PROM remote from labor to limit chorioamnionitis risk

Admission labs for the laboring patient:

Fetal monitoring tier:

Ultrasound at bedside:

Ruptured membranes evaluation:

Board pearl: GBS prophylaxis: penicillin G 5 million units IV load, then 2.5–3 million units q4h until delivery. Penicillin-allergic, low anaphylaxis risk → cefazolin. High anaphylaxis risk → clindamycin only if susceptibility confirmed; otherwise vancomycin.

Step 3 management: A patient at 39w with SROM 12 h ago, no contractions, GBS positive — admit, begin penicillin, initiate oxytocin induction (latent labor induction reduces chorioamnionitis vs expectant management per ARRIVE/TermPROM data).

Advanced Diagnostics — Characterizing the Abnormal Labor Curve

— Plot dilation vs time; serial SVEs q2h in active phase (more often if concerns)

— Identify protraction (slope below expected) vs arrest (flat line)

— Median nullipara takes >6 h to go from 4 → 6 cm

— Active phase acceleration occurs at 6 cm, not 4 cm

— 95th percentile for stage 1 in nulliparas approaches 30 h — patience before diagnosing arrest in latent phase prevents unnecessary cesarean

— Place when external toco is unreliable (obese patient, need for precise titration)

— Calculate MVU: peak pressure minus baseline tone, summed over 10 min

— ≥200 MVU = adequate; ≥250–275 MVU sometimes targeted before declaring arrest

— Acceleration in response = reassuring (rules out significant acidemia)

— Used to evaluate Category II tracings

— pH <7.20 → expedite delivery

— Indicated for recurrent variable decelerations due to cord compression (oligohydramnios)

— Not routinely for meconium

— Confirms OP malposition; transperineal US measures angle of progression and head-perineum distance to predict operative vaginal delivery success

Partograph/labor curve documentation:

Modern (Zhang) labor curve key points:

Quantifying contraction adequacy with IUPC:

Fetal scalp stimulation / vibroacoustic stimulation:

Fetal scalp pH/lactate (rarely used in US, more in Europe):

Amnioinfusion:

Bedside US in stage 2:

CCS pearl: In suspected active-phase arrest, the workup order is: SVE → IUPC → adequate oxytocin titration for ≥4 h at ≥200 MVU → reassess. Only after this sequence is cesarean for "arrest of dilation" appropriate. Documenting these steps is critical for medicolegal defense.

Key distinction: Failed induction (cannot reach active phase after 12–18 h of oxytocin with ruptured membranes) ≠ active-phase arrest — both may end in cesarean but represent different clinical entities.

Management Logic — First-Line Approach to Abnormal Labor

— Inadequate contractions → augment with oxytocin (low-dose or high-dose protocol)

— Ensure adequate hydration, empty bladder, position changes

— Consider amniotomy if membranes intact (AROM) to enhance contractions and allow IUPC/scalp electrode

— Malposition (OP, OT): maternal position changes (hands-knees for OP), manual rotation, or operative rotation

— Macrosomia: if suspected and arrest occurs → cesarean; do not attempt forceps/vacuum with suspected fetopelvic disproportion

— Asynclitism: often resolves with descent; manual correction if persistent

— Empty bladder (foley if needed) — full bladder is a reversible cause of arrest of descent

— Pelvimetry suggesting true contracted pelvis is rare; clinical adequacy assessed during labor

— Prolonged latent phase alone is not an indication for cesarean

— Therapeutic rest (morphine), hydration, or oxytocin/AROM if patient desires augmentation

— Oxytocin augmentation, AROM, expectant management

— Cesarean delivery is indicated

— Reassess position, station, EFW

— Options: continued pushing if reassuring, operative vaginal delivery (forceps/vacuum) if criteria met, or cesarean

Once dystocia is identified, work through the 3 P's systematically:

Power (most modifiable):

Passenger:

Passage:

Latent phase management:

Active phase protraction:

Active phase arrest (≥6 cm, ROM, ≥4 h adequate or ≥6 h inadequate contractions):

Stage 2 arrest:

Step 3 management: ACOG "Safe Prevention of the Primary Cesarean" recommends allowing ≥4 h of adequate contractions at ≥6 cm before diagnosing arrest, and allowing ≥3 h pushing for nulliparas (≥4 h with epidural) before stage 2 arrest — these thresholds are heavily tested.

Board pearl: Failed induction at term is not declared until ≥12–18 h of oxytocin after membrane rupture without active-phase entry.

Pharmacotherapy — Oxytocin, Analgesia, and Adjuncts

— Low-dose protocol: start 1–2 mU/min, increase by 1–2 mU/min q15–40 min

— High-dose protocol: start 4–6 mU/min, increase by 4–6 mU/min q15–40 min

— Titrate to adequate contractions (3–5 in 10 min, ≥200 MVU) without tachysystole

— Max typically 20–40 mU/min

— With Category I tracing: reduce oxytocin

— With Category II/III: stop oxytocin, lateral position, IV fluid bolus, O₂ if hypoxic, consider terbutaline 0.25 mg SC for tocolysis

— Mechanical: Foley balloon, Cook catheter

— Prostaglandins: misoprostol (PGE1) 25 mcg PV q3–6h OR dinoprostone (PGE2) vaginal insert

— Contraindication to prostaglandins: prior cesarean/uterine surgery (risk of rupture with misoprostol is unacceptable)

— Neuraxial (epidural): gold standard; may slightly prolong stage 2 but does not increase cesarean rate

— IV opioids (fentanyl, nalbuphine, remifentanil PCA): used when neuraxial contraindicated (coagulopathy, infection at site, low platelets <70k, patient refusal)

— Nitrous oxide 50/50 with O₂: increasingly available

— Ampicillin + gentamicin intrapartum; add clindamycin or metronidazole if cesarean for anaerobic coverage

Oxytocin (Pitocin) — first-line uterotonic for augmentation/induction:

Tachysystole (>5 contractions/10 min averaged over 30 min):

Cervical ripening (Bishop score <6) before oxytocin:

Analgesia options:

GBS prophylaxis: penicillin G; cefazolin (low-risk PCN allergy); clindamycin or vancomycin (high-risk)

Antibiotics for intraamniotic infection (Triple I):

Magnesium sulfate: neuroprotection for anticipated delivery <32 weeks; seizure prophylaxis in preeclampsia with severe features

Board pearl: Misoprostol is contraindicated in patients with prior cesarean due to rupture risk; mechanical ripening (Foley) is preferred when ripening is needed in TOLAC candidates, though many institutions avoid pharmacologic induction entirely in TOLAC.

Procedures — Operative Vaginal Delivery, Cesarean, and Dystocia Maneuvers

— Prerequisites (must memorize):

— Fully dilated, ruptured membranes, engaged head (≥+2 station), known position, adequate analgesia, empty bladder, no suspected CPD, experienced operator, ability to perform emergent cesarean

— Vacuum: max 3 pop-offs, ≤20 min application, ≥34 weeks (avoid <34w due to IVH risk)

— Forceps: more force, requires more skill; lower failure rate than vacuum

— Complications: maternal lacerations, neonatal cephalohematoma, subgaleal hemorrhage (vacuum), facial nerve palsy (forceps)

— Active-phase arrest at ≥6 cm with adequate contractions

— Stage 2 arrest not amenable to OVD

— Category III FHR tracing

— Cord prolapse, placental abruption with non-reassuring fetus

— HELPERR mnemonic:

— Help (call team), Evaluate for episiotomy, Legs (McRoberts: hyperflex thighs onto abdomen), Pressure (suprapubic, NOT fundal), Enter (rotational maneuvers: Rubin, Woods corkscrew), Remove posterior arm, Roll (Gaskin all-fours)

— Last resort: Zavanelli (cephalic replacement + cesarean), symphysiotomy

— Never apply fundal pressure — worsens impaction and risks rupture

— Manual extraction under anesthesia, then uterotonics

— Uterotonics: oxytocin (1st), methylergonovine (avoid in HTN), carboprost/hemabate (avoid in asthma), misoprostol

— Tranexamic acid 1 g IV within 3 h of delivery

— Tamponade (Bakri balloon), B-Lynch suture, uterine artery embolization, hysterectomy

Operative vaginal delivery (OVD) — forceps or vacuum:

Cesarean delivery indications in dystocia:

Shoulder dystocia — obstetric emergency after head delivery, "turtle sign":

Retained placenta (stage 3 >30 min):

Postpartum hemorrhage management:

CCS pearl: For shoulder dystocia, first maneuver = McRoberts + suprapubic pressure — resolves 50–60% of cases. Document time elapsed, maneuvers performed, and order; medicolegally critical given brachial plexus injury risk.

Special Populations — Older Gravidas and Medical Comorbidities

— Higher rates of dystocia, cesarean, GDM, hypertensive disorders, stillbirth

— Consider delivery by 39w0d–39w6d in selected patients; ACOG supports 39–40w delivery for maternal age ≥40

— More vigilant FHR monitoring; lower threshold for cesarean if abnormal labor patterns

— Difficulty with external monitoring → consider fetal scalp electrode and IUPC earlier

— Higher cesarean rates, wound complications, VTE risk

— VTE prophylaxis post-cesarean with sequential compression devices ± LMWH

— Anesthesia consult early — neuraxial placement may be technically difficult

— Continuous BP monitoring; treat severe range BP (≥160/110) within 30–60 min with IV labetalol, hydralazine, or PO nifedipine

— Magnesium sulfate for seizure prophylaxis in severe features

— Avoid methylergonovine for PPH (causes severe HTN)

— Insulin drip with glucose target 70–110 mg/dL intrapartum

— Macrosomia → higher shoulder dystocia risk; scheduled cesarean if EFW ≥4500 g

— Avoid Valsalva in severe disease → assisted second stage with OVD

— Avoid ergot alkaloids and high-dose oxytocin boluses (hypotension)

— Adjust magnesium dose (renally cleared) — monitor reflexes, RR, urine output; calcium gluconate for toxicity

— Avoid NSAIDs for postpartum analgesia in significant CKD or preeclampsia with renal involvement

— Coagulopathy contraindicates neuraxial anesthesia until corrected

Advanced maternal age (≥35):

Obesity (BMI ≥30, especially ≥40):

Chronic hypertension / preeclampsia:

Diabetes (pregestational or GDM):

Cardiac disease:

Renal impairment:

Hepatic disease (HELLP, AFLP):

Step 3 management: A patient with severe preeclampsia on magnesium develops respiratory depression and absent reflexes → stop magnesium, administer calcium gluconate 1 g IV, assess airway. Check magnesium level.

Board pearl: Methylergonovine is contraindicated in hypertension/preeclampsia; carboprost is contraindicated in asthma — choose accordingly for PPH.

Special Populations — TOLAC, Multiples, Preterm, and Adolescents

— Candidates: 1 prior low-transverse cesarean, no other uterine scar, no contraindication to vaginal delivery, facility with immediate cesarean capability

— Contraindications: prior classical or T-incision, prior uterine rupture, ≥2 prior cesareans (controversial; some allow), placenta previa

— Success ~60–80%; calculate with VBAC calculator

— Uterine rupture risk: 0.5–0.9% with 1 prior LTCS; signs = fetal bradycardia (most common, ~70%), abdominal pain, loss of station, vaginal bleeding, hemodynamic instability

— Induction: mechanical (Foley) preferred; avoid misoprostol; oxytocin acceptable with caution

— Di-di or di-mo with twin A vertex: vaginal delivery acceptable

— Twin A non-vertex: cesarean

— Mono-mono twins: cesarean at 32–34w

— After twin A delivers, assess twin B presentation; internal podalic version + breech extraction is standard for non-vertex twin B with experienced operator

— Antenatal corticosteroids (betamethasone) 24w0d–33w6d (and 34w0d–36w6d if at risk of preterm delivery within 7 days and no prior steroids)

— Magnesium for neuroprotection <32w

— Tocolytics (nifedipine, indomethacin) to allow steroid course (48 h)

— GBS prophylaxis if status unknown

— Higher rates of preterm birth, preeclampsia

— Confidentiality nuances; in most states, pregnant minors can consent to their own pregnancy-related care

— Offer external cephalic version (ECV) at 36–37w (success ~50–60%)

— Planned cesarean for persistent breech (Term Breech Trial)

Trial of labor after cesarean (TOLAC) / VBAC:

Twin gestation:

Preterm labor:

Adolescent gravidas:

Breech presentation at term:

Key distinction: Suspected uterine rupture in TOLAC = emergent laparotomy; most common presenting sign is abrupt fetal bradycardia, NOT pain. This is a frequent Step 3 vignette.

Complications and Adverse Outcomes

— Postpartum hemorrhage (PPH): blood loss ≥1000 mL or symptomatic; uterine atony is #1 cause; risk factors include prolonged labor, chorioamnionitis, macrosomia, multiparity, oxytocin use

— Chorioamnionitis (Triple I): prolonged ROM, multiple SVEs, prolonged labor; treat with ampicillin + gentamicin

— Endometritis (postpartum): polymicrobial; clindamycin + gentamicin is standard; add ampicillin if no clinical improvement in 48 h

— Obstetric lacerations: 3rd degree (anal sphincter), 4th degree (rectal mucosa) — repair in OR, stool softeners, sitz baths

— Uterine rupture, inversion, atony

— Venous thromboembolism: pregnancy and postpartum are hypercoagulable states

— Postpartum depression and PTSD after traumatic birth

— Hypoxic-ischemic encephalopathy (HIE): from prolonged labor, cord compression, abruption; therapeutic hypothermia within 6 h if criteria met

— Shoulder dystocia sequelae:

— Brachial plexus injury (Erb palsy C5-C6 most common — "waiter's tip"; most resolve spontaneously)

— Clavicle fracture, humeral fracture

— Hypoxic injury

— Cephalohematoma (subperiosteal, doesn't cross suture lines) vs caput succedaneum (crosses sutures) vs subgaleal hemorrhage (life-threatening with vacuum)

— Meconium aspiration syndrome

— Birth asphyxia with low Apgar; cord gas pH <7.0 + base deficit ≥12 indicates significant acidosis

Maternal complications:

Fetal/neonatal complications:

Step 3 management: Newborn with shoulder dystocia delivery and arm hanging limply with hand in "waiter's tip" — Erb palsy. Management: gentle ROM, physical therapy referral, reassess at 4–6 weeks; most resolve by 6 months; persistent deficits warrant neurosurgical/orthopedic referral by 3–9 months.

Board pearl: Subgaleal hemorrhage after vacuum delivery is a neonatal emergency — boggy scalp swelling crossing suture lines, can sequester entire blood volume; transfer to NICU for monitoring and transfusion.

When to Escalate — Emergent Delivery and Multidisciplinary Activation

— Cord prolapse: elevate presenting part with hand, knee-chest or Trendelenburg, fill bladder with saline, immediate cesarean

— Placental abruption with fetal compromise

— Uterine rupture

— Persistent fetal bradycardia <70 bpm not responding to intrauterine resuscitation

— Category III tracing

— Left lateral position (relieve IVC compression)

— IV fluid bolus (lactated Ringer's 500–1000 mL)

— Discontinue oxytocin

— O₂ via nonrebreather (limited evidence; still common)

— Tocolysis (terbutaline 0.25 mg SC) if tachysystole

— Amnioinfusion for variable decelerations from cord compression

— Treat maternal hypotension (especially post-epidural): phenylephrine preferred, ephedrine acceptable

— PPH ≥1500 mL or hemodynamic instability

— 1:1:1 ratio of pRBC:FFP:platelets

— MFM for high-risk antepartum

— Anesthesia early for obesity, cardiac disease, coagulopathy

— NICU for preterm, meconium, anticipated resuscitation

— Surgery/urology for accreta spectrum, complex repairs

— Social work for substance use, IPV, lack of support

Indications for emergent cesarean ("crash" or category 1, decision-to-delivery ≤30 min, often <15):

Intrauterine resuscitation maneuvers (first-line for Category II/III before going to OR):

Massive transfusion protocol activation:

Consults:

CCS pearl: Cord prolapse on exam → do not remove your hand; elevate fetal head off the cord, call for emergent cesarean, position patient knees-to-chest or steep Trendelenburg, consider bladder filling with 500 mL saline via Foley to lift presenting part. Tocolysis (terbutaline) buys time.

Key distinction: Category II tracings are managed with resuscitation and reassessment, not immediate delivery. Category III = move to delivery.

Key Differentials — Other Causes of Slow Labor Progress

— Nullipara >20 h, multipara >14 h

— Often misdiagnosed as labor; cervix <6 cm

— Management: therapeutic rest (morphine), hydration, or augmentation; not an indication for cesarean alone

— True bony disproportion is uncommon; usually a retrospective diagnosis after failed labor

— Suggested by high station despite full dilation, significant caput/molding, OP/OT malposition

— Persistent OP (5–8% at delivery): prolonged labor, back pain, more lacerations

— Transverse arrest (OT): head fails to rotate to OA

— Management: maternal position changes (hands-knees), manual rotation, OVD with rotation, or cesarean

— Breech (3–4% at term): frank, complete, footling

— Face (mentum anterior may deliver vaginally; mentum posterior → cesarean)

— Brow: usually converts to face or vertex; persistent brow → cesarean

— Transverse lie / shoulder presentation: cesarean

— Compound presentation (hand alongside head): often resolves; observe

— Hypotonic dysfunction (most common power problem) — responds to oxytocin

— Hypertonic/incoordinate uterine activity (rare) — therapeutic rest, hydration

— Rare; pathologic retraction ring marker for impending rupture in obstructed labor

When labor appears stalled, exclude these dystocia mimickers and same-category entities:

Prolonged latent phase (not true dystocia):

Cephalopelvic disproportion (CPD):

Malposition:

Malpresentation:

Inadequate uterine activity:

Constriction ring (Bandl's ring):

Board pearl: Face presentation with mentum anterior can deliver vaginally; mentum posterior cannot and requires cesarean — the chin cannot extend further under the symphysis.

Key distinction: Brow presentation is unstable and usually converts; face presentation is stable once established.

Key Differentials — Non-Labor Causes of Abdominal Pain and Bleeding

— Painful vaginal bleeding, tender rigid uterus, possible fetal compromise

— Risk factors: hypertension, trauma, cocaine, smoking, prior abruption, PPROM

— Management: continuous EFM, IV access, type/cross, delivery if maternal/fetal instability or term

— Concealed abruption may have little visible bleeding

— Painless bright red vaginal bleeding in late pregnancy

— No digital exam until US excludes previa

— Cesarean delivery; consider accreta spectrum especially with prior cesarean + anterior previa

— Painless bleeding with fetal exsanguination — rapid fetal bradycardia/sinusoidal pattern after ROM

— Antenatal diagnosis warrants scheduled cesarean at 34–35w

— Sudden fetal bradycardia, abdominal pain, loss of station, hemodynamic instability — emergent laparotomy

— Maternal fever + one of: maternal tachycardia, fetal tachycardia, uterine tenderness, purulent discharge, leukocytosis

— Treat with ampicillin + gentamicin; expedite delivery

— Pain may localize higher (RUQ) due to displaced cecum; nausea, fever, leukocytosis

— US first, MRI second; surgery indicated

— Fever, flank pain, dysuria; precipitates preterm labor

— IV ceftriaxone, then oral suppression

— RUQ pain, nausea, hemolysis, elevated LFTs, low platelets → delivery

— Sudden dyspnea, tachycardia, hypoxia; pregnancy is hypercoagulable; D-dimer unreliable, get CTPA or V/Q

Conditions that mimic or complicate labor and must be distinguished:

Placental abruption:

Placenta previa:

Vasa previa:

Uterine rupture:

Chorioamnionitis (Triple I):

Acute appendicitis in pregnancy:

Pyelonephritis:

HELLP syndrome:

Pulmonary embolism:

Step 3 management: A 32w patient on TOLAC has sudden fetal bradycardia and loses station — suspect uterine rupture, emergent cesarean/laparotomy, type/cross 4 units, alert anesthesia and OR team.

Postpartum Plan — Discharge Medications and Secondary Prevention

— Vital signs and bleeding checks q15 min × 4 → q30 min × 2 → q4h

— Fundal massage if atony

— Encourage early ambulation (VTE prevention) and breastfeeding

— Bladder function monitoring (urinary retention common after epidural/OVD)

— Analgesia: scheduled acetaminophen + ibuprofen first-line; limit opioids, prescribe smallest quantity if needed (opioid stewardship)

— Stool softeners (docusate) — especially after 3rd/4th degree lacerations

— Iron if anemic

— RhoGAM 300 mcg IM within 72 h postpartum if Rh-negative mother and Rh-positive infant

— Rubella and varicella vaccines if non-immune (live vaccines OK postpartum, even while breastfeeding)

— Tdap if not given antenatally

— Immediate postpartum LARC (IUD, implant) is safe and reduces short-interval pregnancy

— Avoid combined estrogen-containing contraceptives <21 days postpartum (VTE risk); <30 days if breastfeeding with other VTE risks

— Progestin-only methods safe immediately

— Permanent contraception (tubal ligation) if requested and counseled

— GDM: 6–12 week postpartum 75-g OGTT (not A1c)

— Preeclampsia/hypertensive disorders: BP check within 72 h and at 7–10 days; lifelong 2× CV risk — counsel on lifestyle, statin/ASA consideration later in life

— Preterm birth: progesterone for next pregnancy if indicated

— PPH: document risk factors, plan for active management of stage 3 next time

Standard postpartum orders:

Discharge medications:

Contraception counseling before discharge:

Secondary prevention:

Board pearl: A breastfeeding patient who is 3 weeks postpartum requests contraception — avoid combined OCPs; offer progestin-only pill, DMPA, implant, or IUD.

Step 3 management: Active management of the third stage (oxytocin with delivery of anterior shoulder, controlled cord traction, uterine massage) reduces PPH risk by ~60% — standard of care.

Follow-Up, Monitoring, and Counseling

— Initial contact within 3 weeks postpartum (sooner if hypertensive disorders: 3–10 days)

— Comprehensive postpartum visit by 12 weeks

— Higher-risk patients: more frequent

— Mood screening: Edinburgh Postnatal Depression Scale (EPDS) or PHQ-9 — postpartum depression peaks 2–6 months; treat with SSRIs (sertraline first-line for breastfeeding)

— Physical recovery: lochia, perineal/incision healing, breastfeeding issues

— Contraception finalization

— Chronic disease transition: HTN, GDM → diabetes screening (OGTT at 6–12 weeks, then q1–3 years)

— Reproductive life plan: interval to next pregnancy (recommend ≥18 months between pregnancies)

— Resumption of sexual activity counseling

— Pelvic floor: assess for incontinence, dyspareunia, prolapse; refer to pelvic floor PT if indicated

— Future TOLAC eligibility (success rates lower if cesarean was for arrest vs malpresentation)

— Wound care, when to call (fever, drainage, dehiscence)

— Activity restrictions: no heavy lifting >10 lb × 6 weeks

— Risk of recurrence ~10–15%

— Future delivery planning: glycemic control, weight management, EFW assessment

— Pediatric follow-up for brachial plexus injury

— Refer to lactation consultant for difficulty

— Most medications compatible with breastfeeding; check LactMed

Postpartum visit cadence (revised ACOG model):

Postpartum visit content ("4th trimester"):

Counseling after cesarean for dystocia:

Counseling after shoulder dystocia:

Lactation support:

Step 3 management: Postpartum hypertension follow-up — BP check within 3–10 days for any hypertensive disorder of pregnancy; continue antihypertensives and reassess; transition to primary care for long-term CV risk reduction (preeclampsia doubles lifetime CVD risk).

Board pearl: Routine 6-week-only postpartum visit is now considered insufficient; ACOG recommends ongoing engagement starting within 3 weeks.

Ethical, Legal, and Patient Safety Considerations

— Consent for cesarean, OVD, episiotomy should ideally occur antepartum when possible

— In emergencies (fetal distress, cord prolapse), emergency exception allows lifesaving intervention without delayed consent; document thoroughly

— Maternal autonomy: a competent patient may refuse cesarean even with fetal risk; court-ordered cesareans are ethically problematic and rarely upheld

— Birth plans should be respected when safe; deviations require communication and documentation

— TOLAC counseling must include written documentation of risks/benefits and ability to perform emergent cesarean

— Standardized oxytocin protocols reduce hyperstimulation and litigation

— TeamSTEPPS communication, structured handoffs (SBAR), and OB safety bundles (hemorrhage, hypertension, VTE) are AHRQ-endorsed

— Universal screening for IPV, substance use, depression in pregnancy

— Time-outs and surgical safety checklists before cesarean

— Suspected child abuse (newborn with positive toxicology, untreated congenital syphilis, withdrawal); reporting varies by state but suspicion is the threshold

— Suspected IPV: not mandatorily reportable in most states unless injury reportable; offer resources

— Black women have 3–4× higher maternal mortality than white women in the US; severe morbidity gaps similarly large

— Address bias, ensure equitable pain management and respectful maternity care

— Handoff between L&D and postpartum unit — communicate hemorrhage risk, magnesium status, antibiotics

— Discharge with hypertensive disorder — must have BP follow-up within 7–10 days; readmissions for postpartum preeclampsia/eclampsia peak 3–7 days post-discharge

Informed consent in labor:

Shared decision-making:

Patient safety in labor:

Mandatory reporting:

Health disparities (Step 3-relevant):

Transition-of-care risks:

Step 3 management: A G3P2 patient refuses recommended cesarean for arrest of dilation. After thorough counseling about maternal/fetal risks documented in the chart, the team must respect her autonomy; continue supportive care, optimize labor, and prepare for emergent intervention if her status changes. Court orders are not appropriate first-line.

High-Yield Associations and Rapid-Fire Clinical Facts

Friedman vs Zhang: active phase begins at 6 cm, not 4 cm (modern definition)

Arrest of active phase: ≥6 cm + ROM + ≥4 h adequate (≥200 MVU) OR ≥6 h inadequate contractions despite oxytocin

Stage 2 limits: nullipara 3 h (4 h with epidural); multipara 2 h (3 h with epidural)

Failed induction: ≥12–18 h oxytocin after ROM without reaching active phase

Adequate contractions: 3–5 in 10 min, ≥200 MVU

Tachysystole: >5 in 10 min averaged over 30 min

GBS prophylaxis: penicillin G first-line; ≥4 h before delivery is "adequate"

First-line PPH uterotonic: oxytocin; second-line methylergonovine (avoid in HTN); carboprost (avoid in asthma); misoprostol

Tranexamic acid 1 g IV within 3 h for PPH

Shoulder dystocia first maneuver: McRoberts + suprapubic pressure

Cord prolapse: elevate presenting part, knee-chest, emergent cesarean

Misoprostol contraindicated in prior cesarean

Methylergonovine contraindicated in hypertension/preeclampsia

Carboprost contraindicated in asthma

Magnesium toxicity antidote: calcium gluconate

Mg toxicity progression: loss of DTRs → respiratory depression → cardiac arrest

Apgar: 1 and 5 min; does NOT determine resuscitation (resuscitation is based on the NRP algorithm at 30–60 sec)

Cord gas pH <7.0 + base deficit ≥12 = significant acidemia

Therapeutic hypothermia: HIE, within 6 h, ≥36 weeks

Erb palsy: C5–C6, "waiter's tip"; most resolve by 6 months

Klumpke palsy: C8–T1, claw hand

External cephalic version: 36–37 weeks, ~50–60% success

VBAC uterine rupture risk: 0.5–0.9% with prior LTCS

Most common sign of uterine rupture: fetal bradycardia

Postpartum endometritis treatment: clindamycin + gentamicin

Rh prophylaxis: 28 weeks, within 72 h postpartum if infant Rh+, after any sensitizing event

Board pearl: Decision-to-delivery interval for emergent cesarean: ≤30 minutes (national standard).

Board Question Stem Patterns

— G1P0 at 40w, 7 cm × 4 h with MVU 230, no change → diagnose active phase arrest → cesarean delivery

— Distractor: continued oxytocin (wrong if criteria for arrest met)

— Nullipara pushing 3.5 h with epidural, OA, +2 station, reassuring FHR → operative vaginal delivery if prerequisites met; otherwise cesarean

— Head delivers, retracts ("turtle sign"), shoulder impacted → call for help, McRoberts, suprapubic pressure first

— Distractors: fundal pressure (NEVER), immediate Zavanelli (last resort)

— SROM, fetal bradycardia, palpable cord → elevate presenting part, knee-chest, emergent cesarean

— TOLAC patient with sudden fetal bradycardia, loss of station, abdominal pain → emergent laparotomy

— Oxytocin running, contractions 6/10 min, late decels → stop oxytocin, lateral position, IV bolus, O₂, consider terbutaline

— Boggy uterus, atony → uterine massage, oxytocin first; if no response → methylergonovine (check BP) → carboprost (check asthma) → misoprostol

— Severe preeclampsia on Mg, now areflexic, RR 8 → stop Mg, give calcium gluconate

— Maternal fever 39°C, fetal tachycardia, prolonged ROM → ampicillin + gentamicin, expedite delivery; add clindamycin if cesarean

— Prior LTCS for breech, vertex now → offer TOLAC; quote ~0.7% rupture risk, 70% success

— Boggy diffuse scalp swelling crossing sutures → subgaleal hemorrhage, NICU

— Macrosomic infant post-shoulder dystocia, arm in "waiter's tip" → Erb palsy, PT, most resolve by 6 mo

Pattern 1 — Active phase arrest:

Pattern 2 — Stage 2 arrest with reassuring tracing:

Pattern 3 — Shoulder dystocia:

Pattern 4 — Cord prolapse:

Pattern 5 — Uterine rupture:

Pattern 6 — Tachysystole with Category II:

Pattern 7 — Postpartum hemorrhage:

Pattern 8 — Magnesium toxicity:

Pattern 9 — Chorioamnionitis:

Pattern 10 — TOLAC counseling:

Pattern 11 — Newborn after vacuum:

Pattern 12 — Erb palsy:

Step 3 management: Many vignettes will test the next best step under time pressure — memorize the maneuver order for shoulder dystocia, the resuscitation order for Category II tracings, and the uterotonic ladder for PPH.

One-Line Recap

— Stage 1 latent (0→6 cm), active (6→10 cm)

— Stage 2 (full → delivery): nullipara 3 h (4 h epidural), multipara 2 h (3 h epidural)

— Stage 3 (delivery → placenta): ≤30 min; active management reduces PPH

— Stage 4: first 1–2 h postpartum

— Active arrest: ≥6 cm, ROM, ≥4 h adequate (≥200 MVU) or ≥6 h inadequate contractions

— Failed induction: ≥12–18 h oxytocin after ROM without active phase

— Stage 2 arrest: exceed time limits above

— Shoulder dystocia → McRoberts + suprapubic pressure

— Cord prolapse → elevate, knee-chest, emergent cesarean

— Uterine rupture (TOLAC) → emergent laparotomy

— PPH → oxytocin → methylergonovine → carboprost → misoprostol + TXA

— Mg toxicity → stop Mg, calcium gluconate

Core teaching: Normal labor is divided into three stages with redefined modern thresholds (active phase begins at 6 cm), and labor dystocia — arrest of dilation, arrest of descent, or failed induction — is diagnosed only after documented adequate contractions and sufficient time have been allowed, with management driven by the systematic evaluation of Power, Passenger, and Passage and reservation of cesarean for true arrest, non-reassuring fetal status, or unsafe operative vaginal delivery conditions.

Stages snapshot:

Dystocia diagnostic thresholds:

Emergencies and first moves:

Board pearl: The single most testable Step 3 concept is that active phase begins at 6 cm and arrest requires ≥4 h of adequate contractions — diagnosing arrest before these thresholds drives unnecessary primary cesareans and is a wrong answer on the exam.